Ligand validation:6O4H

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 6O4H designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6O4H_NAD_F_602	56%	3%	0.14	0.912	5.15	1.36	16	5	1	0	100%	0.8
6O4H_NAD_H_601	55%	3%	0.138	0.907	5.22	1.27	16	6	2	0	100%	0.82
6O4H_NAD_D_601	55%	2%	0.151	0.919	5.24	1.3	16	7	1	0	100%	0.77
6O4H_NAD_B_602	55%	2%	0.147	0.914	5.16	1.39	16	8	0	0	100%	0.8
6O4H_NAD_G_601	54%	2%	0.141	0.905	5.2	1.34	16	6	0	0	100%	0.82
6O4H_NAD_A_601	54%	3%	0.15	0.913	5.17	1.32	15	7	2	0	100%	0.82
6O4H_NAD_E_601	50%	3%	0.144	0.894	5.13	1.29	16	8	0	0	100%	0.8
6O4H_NAD_C_601	46%	2%	0.163	0.898	5.25	1.28	16	5	1	0	100%	0.79
6O4C_NAD_G_601	94%	3%	0.069	0.97	4.99	1.35	16	4	1	0	100%	1
6O4B_NAD_H_601	93%	3%	0.074	0.968	5.16	1.22	15	4	1	0	100%	1
6O4E_NAD_D_601	87%	2%	0.092	0.964	5.15	1.41	16	6	1	0	100%	0.93
6O4L_NAD_A_604	87%	3%	0.095	0.966	5	1.25	15	5	1	0	100%	0.93
4X0T_NAD_B_601	84%	21%	0.108	0.97	2	1.35	14	6	0	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.